Scientists believe drug commonly prescribed for T2 could be routinely taken by T1 patients.

What benefits can lixisenatide provide when added to basal insulin regimen?

Empagliflozin might not only decrease the risk of cardiovascular events in patients with type 2, but also renal events.

Could GLP-1 inhibitors be a useful adjunct therapy in type I diabetes?

Here's another test of your graph-interpreting skills! Follow the link to see this graph at full size and indicate the parameter that best describes Curve 3. 1. Insulin Secretion 2. Postprandial glucose 3. Fasting glucose 4. Insulin Resistance

Starting patients diagnosed within the last 7 years on 2-4 weeks of intensive insulin therapy could help keep them off additional medications for at least 48 weeks.

Studies suggest fenofibrate can prevent microvascular changes, decrease need for surgery.

Tighter glucose and blood pressure control found to decrease incidence.

A phase 2 randomized controlled trial demonstrated clinically significant changes in glycemic control.

Metformin use has been associated with significant disturbances in acid-base balance.